GERON CORP Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31)
GERON CORP (GERN) reported Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) of -$154.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss · last filed 2018-03-16
- GERON CORP available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for the quarter ending 2017-03-31 was -$18.00K, a 107.11% decline year-over-year.
- GERON CORP available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for the quarter ending 2016-12-31 was -$78.00K.
- GERON CORP available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for the quarter ending 2016-09-30 was -$65.00K.
- GERON CORP available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $50.00K.
- GERON CORP available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for fiscal 2017 was -$154.00K, a 196.25% decline from fiscal 2016.
- GERON CORP available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for fiscal 2016 was $160.00K.
- GERON CORP available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for fiscal 2015 was -$129.00K.
- GERON CORP available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for fiscal 2014 was -$70.00K.
| Period end | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$154.00K 10-K · filed 2018-03-16 | |||
| 2017-03-31 | -$18.00K 10-Q · filed 2017-05-09 | -$96.00K derived: sum of 2 quarters · filed 2018-03-16 | -$161.00K derived: sum of 3 quarters · filed 2018-03-16 | -$111.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$143.00K derived: sum of 2 quarters · filed 2018-03-16 | -$93.00K derived: sum of 3 quarters · filed 2018-03-16 | $160.00K 10-K · filed 2018-03-16 |
| 2016-09-30 | -$65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$15.00K derived: sum of 2 quarters · filed 2016-11-03 | $238.00K 10-Q · filed 2016-11-03 | $82.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $303.00K 10-Q · filed 2016-08-03 | $147.00K derived: sum of 3 quarters · filed 2018-03-16 | $140.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $253.00K 10-Q · filed 2017-05-09 | $97.00K derived: sum of 2 quarters · filed 2018-03-16 | $90.00K derived: sum of 3 quarters · filed 2018-03-16 | $57.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | -$156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$163.00K derived: sum of 2 quarters · filed 2018-03-16 | -$196.00K derived: sum of 3 quarters · filed 2018-03-16 | -$129.00K 10-K · filed 2018-03-16 |
| 2015-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$40.00K derived: sum of 2 quarters · filed 2016-11-03 | $27.00K 10-Q · filed 2016-11-03 | -$21.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $34.00K 10-Q · filed 2016-08-03 | -$14.00K derived: sum of 3 quarters · filed 2017-03-01 | -$30.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $67.00K 10-Q · filed 2016-05-05 | $19.00K derived: sum of 2 quarters · filed 2017-03-01 | $3.00K derived: sum of 3 quarters · filed 2017-03-01 | $73.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$64.00K derived: sum of 2 quarters · filed 2017-03-01 | $6.00K derived: sum of 3 quarters · filed 2017-03-01 | -$70.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $54.00K derived: sum of 2 quarters · filed 2015-11-05 | -$22.00K 10-Q · filed 2015-11-05 | -$24.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$6.00K 10-Q · filed 2015-08-05 | -$8.00K derived: sum of 3 quarters · filed 2016-03-10 | -$7.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | -$76.00K 10-Q · filed 2015-05-07 | -$78.00K derived: sum of 2 quarters · filed 2016-03-10 | -$77.00K derived: sum of 3 quarters · filed 2016-03-10 | -$108.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$1.00K derived: sum of 2 quarters · filed 2016-03-10 | -$32.00K derived: sum of 3 quarters · filed 2016-03-10 | -$54.00K 10-K · filed 2016-03-10 |
| 2013-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$30.00K derived: sum of 2 quarters · filed 2014-11-05 | -$52.00K 10-Q · filed 2014-11-05 | -$94.00K derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$53.00K 10-Q · filed 2014-08-11 | -$95.00K derived: sum of 3 quarters · filed 2015-03-11 | -$85.00K derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-03-31 | -$22.00K 10-Q · filed 2014-05-01 | -$64.00K derived: sum of 2 quarters · filed 2015-03-11 | -$54.00K derived: sum of 3 quarters · filed 2015-03-11 | -$89.00K derived: sum of 4 quarters · filed 2015-03-11 |
| 2012-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | -$32.00K derived: sum of 2 quarters · filed 2015-03-11 | -$67.00K derived: sum of 3 quarters · filed 2015-03-11 | -$38.00K 10-K · filed 2015-03-11 |
| 2012-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$25.00K derived: sum of 2 quarters · filed 2013-11-07 | $4.00K 10-Q · filed 2013-11-07 | $92.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$6.00K 10-Q · filed 2013-08-08 | $82.00K derived: sum of 3 quarters · filed 2014-03-17 | |
| 2012-03-31 | $29.00K 10-Q · filed 2013-05-03 | $117.00K derived: sum of 2 quarters · filed 2014-03-17 | ||
| 2011-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $6.00K 10-K · filed 2014-03-17 | ||
| 2011-09-30 | -$82.00K 10-Q · filed 2012-11-02 | |||
| 2010-12-31 | $306.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |